Accès gratuit
Numéro
Med Sci (Paris)
Volume 19, Numéro 4, Avril 2003
Page(s) 473 - 476
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2003194473
Publié en ligne 15 avril 2003
  1. Vague J. La différenciation sexuelle, facteur déterminant des formes de l’obésité. Presse Med 1947; 30: 339–40. [Google Scholar]
  2. Bamberger CM, Schulte HM, Chrousos GP. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocrinol Rev 1996; 17: 245–61. [Google Scholar]
  3. Tomlinson JW, Stewart PM. Cortisol metabolism and the role of 11β- hydroxysteroid dehydrogenase. Best Pract Res Clin Endocrinol Metab 2001; 15: 61–78. [Google Scholar]
  4. Walker BR. Steroid metabolism in metabolic syndrome X. Best Pract Res Clin Endocrinol Metab 2001; 15: 111–22. [Google Scholar]
  5. Rask E, Olsson T, Soderberg S, et al. Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 2001; 86: 1418–21. [Google Scholar]
  6. Björntorp P, Rosmond R. The metabolic syndrome: a neuroendocrine disorder ? Br J Nutr 2000; 83: S49–57. [Google Scholar]
  7. Jessop DS, Dallman MF, Fleming D, Lightman SL. Resistance to glucocorticoid feedback in obesity. J Clin Endocrinol Metab 2001; 86: 4109–14. [Google Scholar]
  8. Rask E, Walker BR, Söderberg S, et al. Tissuespecific changes in peripheral cortisol metabolism in obese women: increased adipose 11β-hydroxysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metab 2002; 87: 3330–6. [Google Scholar]
  9. Livingstone DEW, Jones GC, Smith K, et al. Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 2000; 141: 560–3. [Google Scholar]
  10. Masuzaki H, Paterson J, Shinyama H, et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001; 294: 2166–70. [Google Scholar]
  11. Katz JR, Mohamed-Ali V, Wood PJ, Yudkin JS, Coppack SW. An in vivo study of the cortisolcortisone shuttle in subcutaneous abdominal adipose tissue. Clin Endocrinol 1999; 50: 63–8. [Google Scholar]
  12. Bujalska IW, Kumar S, Stewart PM. Does central obesity reflect Cushing’s disease of the omentum ? Lancet 1997; 349: 1210–3. [Google Scholar]
  13. Bujalska IJ, Kumar S, Hewinson M, Stewart PM. Differentiation of adipose stromal cells: the roles of glucocorticoids and 11β- hydroxysteroid dehydrogenase. Endocrinology 1999; 140: 3188–96. [Google Scholar]
  14. Paulmyer-Lacroix O, Boullu S, Oliver C, Alessi MC, Grino M. Expression of the mRNA coding for 11β- hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridization study. J Clin Endocrinol Metab 2002; 87: 2701–5. [Google Scholar]
  15. Bujalska IJ, Walker EA, Hewinson M, Stewart PM. A switch in dehydrogenase to reductase activity of 11β- hydroxysteroid dehydrogenase type 1 upon differentiation of human omental adipose stromal cells. J Clin Endocrinol Metab 2002; 87: 1205–10. [Google Scholar]
  16. Bastelica D, Morange P, Berthet B, et al. Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat: evidence of differences between visceral and subcutaneous deposits. Arterioscler Thromb Vasc Biol 2002; 22: 173–8. [Google Scholar]
  17. Seckl JR, Walker BR. 11β- hydroxysteroid dehydrogenase type 1: a tissue-specific amplifier of glucocorticoid action. Endocrinology 2001; 142: 1371–6. [Google Scholar]
  18. Weaver JU, Thaventhiran L, Noonan N, et al. The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults. Clin Endocrinol (Oxf) 1994; 41: 639–48. [Google Scholar]
  19. Berger J, Tanen M, Elbrecht A, et al. Peroxisome proliferator-activated receptor-γ ligands inhibit adipocyte 11β- hydroxysteroid dehydrogenase type 1 expression and activity. J Biol Chem 2001; 276: 12629–35. [Google Scholar]
  20. Kelly IE, Han TS, Walsh K, Lean MEJ. Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes. Diabetes Care 1999; 22: 288–93. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.